• WRN Loss, MSI, and p53/PUMA in Colon Cancer

  2026-08-16

  The 2022 PNAS study identifies p53 and PUMA-mediated apoptosis as the mechanism underlying the synthetic-lethal dependence of microsatellite-unstable colorectal cancer on Werner helicase. Its genetic, isogenic, and xenograft experiments clarify why p53 status is a major determinant of response and provide a framework for interpreting ML216-based RecQ helicase experiments.

• Alcian Blue & Nuclear Fast Red: Assay Logic

  2026-08-15

  The Alcian Blue & Nuclear Fast Red Staining Kit pH2.5 provides a chemically targeted readout of acid mucins and matrix-rich differentiation. This guide connects staining chemistry, assay controls, and biopsy-processing evidence to support more defensible histological decisions.

• Biotin-16-UTP for RNA Labeling Workflows

  2026-08-14

  Biotin-16-UTP provides a biotin-labeled uridine triphosphate for generating RNA that can be captured or detected through streptavidin or anti-biotin proteins. It is suited to in vitro transcription RNA labeling, RNA detection and purification, and RNA-protein interaction studies, but assay-specific incorporation efficiency and biological performance should be validated rather than assumed.

• VER 155008: HSP 70 Inhibitor Workflows

  2026-08-14

  Build mechanism-led cancer research workflows around VER 155008, from Hsp70 ATPase assays to apoptosis and colon carcinoma models. The same reagent also enables a carefully bounded investigation of HSC70-dependent viral internalization without implying that antiviral activity has been established.

• Ceruletide for Pancreatic Fibrosis Research

  2026-08-13

  Ceruletide, also known as Caerulein in experimental literature, enables controlled CCK-receptor stimulation for pancreatic injury, fibrosis, secretion, and motility workflows. This practical guide connects model induction with ORM2–ZG16 autophagy biology, assay design, formulation choices, and troubleshooting.

• FAM83A, Mitochondria, and White Adipocyte Differentiation

  2026-08-13

  The reference study identifies FAM83A as a regulator of white adipocyte differentiation that links casein kinase 1 activity with mitochondrial maintenance and lipogenesis. By delivering FAM83A-directed sgRNA/Cas9 to adipose tissue, the authors show that FAM83A loss reduces adipose expansion, disrupts mitochondrial function, and limits lipid droplet formation.

• Bay 11-7821 for NF-κB Inflammation Research

  2026-08-12

  Bay 11-7821 (BAY 11-7082) helps separate NF-κB-dependent cytokine production from upstream receptor signaling in infection and inflammation models. This practical guide translates recent CPSIT_0844–TLR2/TLR4 findings into assay workflows, controls, and troubleshooting strategies while extending the compound’s use to apoptosis and cancer research.

• Cardiogreen: From Vascular Signal to Immune Leverage

  2026-08-12

  Cardiogreen (Indocyanine Green) is more than a near-infrared vascular probe. Its protein-bound, intravascular behavior supports quantitative diagnostics, while its photochemical utility creates a translational bridge to cell-death biology and immune-enabled tumor therapy. This article interprets recent oral squamous cell carcinoma findings through a practical framework for assay design, evidence boundaries, and clinical translation.

• MMP-Responsive Hydrogel for Fibrous Dysplasia

  2026-08-11

  This preclinical study develops an injectable hyaluronic acid hydrogel containing triglycerol monostearate nanoparticles to deliver the RANKL inhibitor AS2676293 in response to lesion-associated matrix metalloproteinases. In a GNASR201C fibrous dysplasia mouse model, local treatment reduced lesion progression and improved bone microarchitecture, supporting a lesion-responsive alternative to sustained systemic RANKL inhibition.

• PX-478 2HCl: Designing Better HIF-1α Assays

  2026-08-11

  PX-478 2HCl is a versatile HIF-1α perturbation tool for linking hypoxia biology to measurable phenotypes. This guide focuses on model selection, temporal dosing, orthogonal readouts, and the practical lessons of a prenatal hypoxia study.

• ATS-9R for Adipocyte Gene Silencing

  2026-08-10

  ATS-9R enables targeted, non-viral nucleic-acid delivery to mature adipocytes and selected adipose-tissue populations through Prohibitin-mediated uptake. This practical guide covers complex formation, adipocyte screening, in vivo dosing logic, assay selection, and troubleshooting for obesity-associated inflammation and insulin resistance research.

• HotStart™ 2X Green qPCR Master Mix Guide

  2026-08-09

  HotStart™ 2X Green qPCR Master Mix supports SYBR Green real-time PCR when researchers need a premixed reagent with antibody-mediated Taq polymerase hot-start inhibition. It is appropriate for cDNA or DNA quantification, gene expression analysis, and RNA-seq validation, but should not be treated as a probe-based assay reagent or used without melt-curve and control-based specificity checks.

• Live-Dead Cell Staining Kit Workflow Guide

  2026-08-08

  Build a reproducible cell viability assay with Calcein-AM and Propidium Iodide for microscopy, flow cytometry, biomaterial screening, and drug cytotoxicity testing. This practical guide connects dual-fluorescence readouts with controls, quantitative gating, and troubleshooting for more defensible live/dead measurements.

• GSK2606414: Translating PERK Biology into Strategy

  2026-08-07

  GSK2606414 offers translational researchers a selective way to test how PERK-dependent translational control connects ER stress with inflammation, pyroptosis, cancer biology, and disease-model phenotypes. This article interprets recent nucleus pulposus cell findings, outlines a validation workflow, and explains how to use pharmacology without overstating what current evidence proves.

• Cepharanthine: Mechanistic Power and Translational Opportuni

  2026-08-07

  Cepharanthine, a biscoclaurine alkaloid, is redefining translational research strategies in apoptosis, endometriosis, and cancer therapy. This thought-leadership article synthesizes mechanistic insight, experimental best practices, and strategic guidance, empowering researchers to accelerate bench-to-bedside impact while highlighting the unique advantages and validated protocols of high-purity Cepharanthine from APExBIO.

15991 records 1/1067 page Next 12345 下5页 Last page